Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier $4.9 billion deal and intensifying the race for dominance in the lucrative obesity drug market.
Morgan Wallen announces 'Still the Problem' 2026 stadium tour, highlighting his continued commercial success despite past controversies.
Advance Auto Parts beats Q3 expectations, raises full-year guidance, and sees strong operational improvements.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier $4.9 billion deal and intensifying the race for dominance in the lucrative obesity drug market.
Morgan Wallen announces 'Still the Problem' 2026 stadium tour, highlighting his continued commercial success despite past controversies.
Advance Auto Parts beats Q3 expectations, raises full-year guidance, and sees strong operational improvements.